3rd Circ. Backs $1M FBAR Penalty Against Ex-Pharma CEO
By David Hansen · July 22, 2022, 5:02 PM EDT
A former pharmaceutical CEO faces almost $1 million in penalties for failing to report his Swiss bank accounts after a Third Circuit panel Friday affirmed a lower court ruling that his...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login